Approaches and methods in gene therapy for kidney disease

Journal of Pharmacological and Toxicological Methods
Els A van der WoudenLeo E Deelman

Abstract

Renal gene therapy may offer new strategies to treat diseases of native and transplanted kidneys. Several experimental techniques have been developed and employed using nonviral, viral, and cellular vectors. The most efficient vector for in vivo transfection appears to be adenovirus. Glomeruli, blood vessels, interstitial cells, and pyelum can be transfected with high efficiency. In addition, electroporation and microbubbles with ultrasound, both being enhanced naked plasmid techniques, offer good opportunities. Trapping of mesangial cells into the glomeruli as well as natural targeting of monocytes or macrophages to inflamed kidneys are elegant methods for site-specific delivery of genes. For gene therapy in kidney transplantation, hemagglutinating virus of Japan liposomes are efficient vectors for tubular transfection, whereas enhanced naked plasmid techniques are suitable for glomerular transfection. However, adenovirus offers the best opportunities in a renal transplantation setup because varying parameters of graft perfusion allows targeting of different cell types. In renal grafts, lymphocytes can be used for selective targeting to sites of inflammation. In conclusion, for both in vivo and ex vivo renal transfection, enha...Continue Reading

References

Nov 1, 1990·Kidney International·A S WoolfL G Fine
Apr 1, 1994·Kidney International·P MoullierN Ferry
Mar 15, 1996·Transplantation·S T ZeiglerJ A Thompson
Jan 1, 1996·American Journal of Nephrology·H RabbG Ramirez
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·R P TomkoL Philipson
Jul 1, 1997·Human Gene Therapy·A BolettaL Monaco
May 1, 1997·Gene Therapy·L W LaiY H Lien
Feb 14, 1998·Kidney International·E Imai, Y Isaka
Apr 29, 1998·The Journal of Clinical Investigation·L W LaiY H Lien
Jul 15, 1998·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·C PellegriniC G McGregor
Sep 7, 1999·Journal of the American Society of Nephrology : JASN·M S LipkowitzM E Klotman
Feb 23, 2000·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·N B KuemmerleJ C Chan
Mar 30, 2000·The Journal of Gene Medicine·G A McDonaldV P Sukhatme
Apr 1, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·I H VosT J Rabelink
Apr 7, 2000·Journal of the American Society of Nephrology : JASN·Susanna TomasoniAriela Benigni
Aug 19, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·L ZouK Yang
Sep 30, 2000·Kidney International·N S NahmanD D Sedmak
Oct 25, 2000·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·S D CassiviS H Keshavjee
Dec 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·H YamagishiY Utsunomiya
Jan 3, 2001·The Journal of Clinical Investigation·K C SonntagC LeGuern
Mar 10, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·V ChetboulJ L Pouchelon
Apr 24, 2001·Journal of the American Society of Nephrology : JASN·Michiko TsujieMasatsugu Hori
Jan 12, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·P Seshidhar ReddySheila Connelly
Jan 24, 2002·Journal of the American Society of Nephrology : JASN·Markus H HammerThomas Ritter
Feb 14, 2002·Kidney International·Alan S Verkman, Baoxue Yang
Feb 28, 2002·Human Gene Therapy·G Luca GusellaPaul E Klotman
Feb 28, 2002·Human Gene Therapy·Hiroki MaruyamaJun-Ichi Miyazaki
May 22, 2002·Biochimica Et Biophysica Acta·Brian G BarnettJoanne T Douglas
Sep 12, 2002·Clinical Pharmacokinetics·Cathryn MahTerence R Flotte
Nov 15, 2002·Transplantation Proceedings·L BrasileG Kootstra

❮ Previous
Next ❯

Citations

Jan 25, 2013·International Journal of Molecular Sciences·Emmanuel MornetTristan Montier
Dec 26, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·J M KułdoJ A A M Kamps
Oct 23, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·A del Pozo-RodríguezJ L Pedraz
Jun 14, 2008·International Journal of Pharmaceutics·M E M DolmanR J Kok
Oct 14, 2011·Journal of Cellular and Molecular Medicine·Krishna M BoiniPin-Lan Li
Apr 16, 2008·European Journal of Pharmacology·Maria SandoviciRobert H Henning
Sep 7, 2011·The American Journal of Pathology·Krishna M BoiniPin-Lan Li
Apr 1, 2006·Tijdschrift voor gerontologie en geriatrie·H F A Diesfeldt
Mar 19, 2011·Current Opinion in Organ Transplantation·Nicolas ChatauretThierry Hauet
May 3, 2012·Nature Reviews. Nephrology·Delphine BonThierry Hauet
Jun 21, 2017·Materials Science & Engineering. C, Materials for Biological Applications·Fatemeh OroojalianMohammad Ramezani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Related Papers

Molecular Therapy : the Journal of the American Society of Gene Therapy
Dean A JacksonHans J Lipps
© 2022 Meta ULC. All rights reserved